Results 211 to 220 of about 513,632 (295)

Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity. [PDF]

open access: yesNPJ Vaccines
Kulakova L   +20 more
europepmc   +1 more source

Rethinking Chlorine: Essential Chemical or Replaceable Risk?

open access: yesChemSusChem, EarlyView.
Chlorine is essential for the production of plastics and pharmaceuticals but poses significant safety and environmental risks. Herein, processes are presented that substitute chlorine or reduce its demand. Where indispensable, trichloride‐ and bichloride‐based ionic liquids could enhance safety and streamline the integration of renewable energy ...
Johannes Schwan   +6 more
wiley   +1 more source

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.

open access: green, 1994
Patrizia Farci   +7 more
openalex   +1 more source

OMIP‐114: A 36‐Color Spectral Flow Cytometry Panel for Detailed Analysis of T Cell Activation and Regulation in Small Human Blood Volumes

open access: yesCytometry Part A, EarlyView.
ABSTRACT This 36‐color flow cytometry panel is designed to characterize multiple lymphocyte compartments, with a focus on T cells, their memory subpopulations, and immune checkpoints in human whole blood samples. In clinical settings, the amount of blood available from patients for scientific research is often limited.
Marie‐Theres Thieme‐Ehlert   +3 more
wiley   +1 more source

Disparities in Linkage to Care Among Children With Hepatitis C Virus in the United States. [PDF]

open access: yesPediatrics
Curtis MR   +5 more
europepmc   +1 more source

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity

open access: bronze, 1993
Peter Simmonds   +7 more
openalex   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Hepatitis C Virus Resistance-Associated Substitutions in Mexico. [PDF]

open access: yesViruses
Jose-Abrego A   +4 more
europepmc   +1 more source

Hepatitis C Antibodies in Patients with Alcoholic Liver Disease Commonly Have an Identifiable Risk Factor

open access: bronze, 1992
John G. McHutchison   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy